Cellular Biomedicine (CBMG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 32,444 | 52,813 | 21,568 | 39,252 | 14,885 |
| Receivables | 751 | 103 | 374 | 453 | 1,052 |
| Inventories | N/A | N/A | N/A | N/A | 391 |
| TOTAL | $34,030 | $54,608 | $23,795 | $40,692 | $16,694 |
| Non-Current Assets | |||||
| PPE Net | 21,434 | 15,194 | 12,973 | 4,118 | 2,769 |
| Investments And Advances | 240 | 240 | 269 | 509 | 5,379 |
| Intangibles | 15,056 | 15,650 | 20,099 | 21,771 | 23,628 |
| Other Non-Current Assets | 26,565 | 21,890 | 4,026 | 1,538 | 990 |
| TOTAL | $63,295 | $52,974 | $37,368 | $27,936 | $32,766 |
| Total Assets | $97,324 | $107,581 | $61,162 | $68,629 | $49,460 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 14,334 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 2,040 | 423 | 225 | 216 | 261 |
| Accrued Expenses | 1,905 | 1,879 | 1,097 | 1,169 | 845 |
| Other current liabilities | 5,368 | 5,711 | 2,325 | 950 | 1,913 |
| TOTAL | $23,673 | $8,041 | $3,676 | $2,364 | $3,019 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 17,934 | 14,322 | 184 | 371 | 76 |
| TOTAL | $17,934 | $14,322 | $184 | $371 | $76 |
| Total Liabilities | $41,607 | $22,363 | $3,860 | $2,735 | $3,096 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 19,355 | 18,081 | 17,004 | 14,281 | 11,984 |
| Common Shares | 20 | 19 | 16 | 14 | 12 |
| Retained earnings | -199,967 | -149,983 | -111,037 | -85,547 | -57,338 |
| Other shareholders' equity | -1,454 | -1,423 | -367 | -1,117 | -116 |
| TOTAL | $55,718 | $85,218 | $57,303 | $65,894 | $46,365 |
| Total Liabilities And Equity | $97,324 | $107,581 | $61,162 | $68,629 | $49,460 |